-
1
-
-
0038798093
-
Cancer incidence and mortality in France over the period 1978-2000
-
Remontet L, Esteve J, Bouvier AM, Grosclaude P, Launoy G, Menegoz F, et al. Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique 2003; 51: 3-30.
-
(2003)
Rev Epidemiol Sante Publique
, vol.51
, pp. 3-30
-
-
Remontet, L.1
Esteve, J.2
Bouvier, A.M.3
Grosclaude, P.4
Launoy, G.5
Menegoz, F.6
-
2
-
-
0142062150
-
Human papillomavirus and cervical cancer-burden and assessment of causality
-
Bosch F, de Sanjose S. Human papillomavirus and cervical cancer-burden and assessment of causality. J Natl Cancer Inst Monogr 2003: 3-13.
-
(2003)
J Natl Cancer Inst Monogr
, pp. 3-13
-
-
Bosch, F.1
De Sanjose, S.2
-
3
-
-
0034243425
-
FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers
-
FIGO Committee on Gynecologic Oncology
-
Benedet JL, Bender H, Jones H, Ngan HY, Pecorelli S. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 2000; 70: 209-62.
-
(2000)
Int J Gynaecol Obstet
, vol.70
, pp. 209-262
-
-
Benedet, J.L.1
Bender, H.2
Jones, H.3
Ngan, H.Y.4
Pecorelli, S.5
-
4
-
-
0038470985
-
Standards, Options and Recommendations for the management of invasive cervical cancer patients (non metastastic)
-
Resbeut M, Fondrinier E, Fervers B, Haie-Meder C, Bataillard A, Lhomme C, et al. Standards, Options and Recommendations for the management of invasive cervical cancer patients (non metastastic). Bull Cancer 2003; 90: 333-46.
-
(2003)
Bull Cancer
, vol.90
, pp. 333-346
-
-
Resbeut, M.1
Fondrinier, E.2
Fervers, B.3
Haie-Meder, C.4
Bataillard, A.5
Lhomme, C.6
-
7
-
-
0028044566
-
Chemotherapy for cervix cancer
-
Omura GA. Chemotherapy for cervix cancer. Semin Oncol 1994; 21: 54-62.
-
(1994)
Semin Oncol
, vol.21
, pp. 54-62
-
-
Omura, G.A.1
-
8
-
-
1542439958
-
The role of chemotherapy in the management of carcinoma of the cervix
-
Thigpen T. The role of chemotherapy in the management of carcinoma of the cervix. Cancer J 2003; 9: 425-32.
-
(2003)
Cancer J
, vol.9
, pp. 425-432
-
-
Thigpen, T.1
-
9
-
-
0021793908
-
Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: A Gynecologic Oncology Group study
-
Bonomi P, Blessing JA, Stehman FB, DiSaia PJ, Walton L, Major FJ. Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 1985; 3: 1079-85.
-
(1985)
J Clin Oncol
, vol.3
, pp. 1079-1085
-
-
Bonomi, P.1
Blessing, J.A.2
Stehman, F.B.3
Disaia, P.J.4
Walton, L.5
Major, F.J.6
-
10
-
-
0019408691
-
Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: A phase II study of the Gynecologic Oncology Group
-
Thigpen T, Shingleton H, Homesley H, Lagasse L, Blessing J. Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group. Cancer 1981; 48: 899-903.
-
(1981)
Cancer
, vol.48
, pp. 899-903
-
-
Thigpen, T.1
Shingleton, H.2
Homesley, H.3
Lagasse, L.4
Blessing, J.5
-
11
-
-
0024561232
-
A randomised comparison of a rapid versus prolonged (24 hr) infusion of cisplatin in therapy of squamous cell carcinoma of the uterine cervix: A Gynecologic Oncology Group study
-
Thigpen JT, Blessing JA, DiSaia PJ, Fowler Jr. WC, Hatch KD. A randomised comparison of a rapid versus prolonged (24 hr) infusion of cisplatin in therapy of squamous cell carcinoma of the uterine cervix: a Gynecologic Oncology Group study. Gynecol Oncol 1989; 32: 198-202.
-
(1989)
Gynecol Oncol
, vol.32
, pp. 198-202
-
-
Thigpen, J.T.1
Blessing, J.A.2
Disaia, P.J.3
Fowler Jr., W.C.4
Hatch, K.D.5
-
12
-
-
0023611941
-
Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: A Southwest Oncology Group Study
-
Alberts DS, Kronmal R, Baker LH, Stock-Novack DL, Surwit EA, Boutselis JG, et al. Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: a Southwest Oncology Group Study. J Clin Oncol 1987; 5: 1791-5.
-
(1987)
J Clin Oncol
, vol.5
, pp. 1791-1795
-
-
Alberts, D.S.1
Kronmal, R.2
Baker, L.H.3
Stock-Novack, D.L.4
Surwit, E.A.5
Boutselis, J.G.6
-
13
-
-
0031023552
-
Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: A Gynecologic Oncology Group study
-
Omura GA, Blessing JA, Vaccarello L, Berman ML, Clarke-Pearson DL, Mutch DG, et al. Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 1997; 15: 165-71.
-
(1997)
J Clin Oncol
, vol.15
, pp. 165-171
-
-
Omura, G.A.1
Blessing, J.A.2
Vaccarello, L.3
Berman, M.L.4
Clarke-Pearson, D.L.5
Mutch, D.G.6
-
14
-
-
0036534291
-
Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: A gynecologic oncology group study
-
Bloss JD, Blessing JA, Behrens BC, Mannel RS, Rader JS, Sood AK, et al. Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol 2002; 20: 1832-7.
-
(2002)
J Clin Oncol
, vol.20
, pp. 1832-1837
-
-
Bloss, J.D.1
Blessing, J.A.2
Behrens, B.C.3
Mannel, R.S.4
Rader, J.S.5
Sood, A.K.6
-
15
-
-
4143135504
-
Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: A gynecologic oncology group study
-
Moore DH, Blessing JA, McQuellon RP, Thaler HT, Cella D, Benda J, et al. Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol 2004; 22: 3113-9.
-
(2004)
J Clin Oncol
, vol.22
, pp. 3113-3119
-
-
Moore, D.H.1
Blessing, J.A.2
McQuellon, R.P.3
Thaler, H.T.4
Cella, D.5
Benda, J.6
-
16
-
-
0034908766
-
Randomized phase III trial of bleomycin, vindesine, mitomycin-C, and cisplatin (BEMP) versus cisplatin (P) in disseminated squamous-cell carcinoma of the uterine cervix: An EORTC Gynecological Cancer Cooperative Group study
-
Vermorken JB, Zanetta G, De Oliveira CF, van der Burg ME, Lacave AJ, Teodorovic I, et al. Randomized phase III trial of bleomycin, vindesine, mitomycin-C, and cisplatin (BEMP) versus cisplatin (P) in disseminated squamous-cell carcinoma of the uterine cervix: an EORTC Gynecological Cancer Cooperative Group study. Ann Oncol 2001; 12: 967-74.
-
(2001)
Ann Oncol
, vol.12
, pp. 967-974
-
-
Vermorken, J.B.1
Zanetta, G.2
De Oliveira, C.F.3
Van Der Burg, M.E.4
Lacave, A.J.5
Teodorovic, I.6
-
17
-
-
23044495279
-
Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: A Gynecologic Oncology Group Study
-
Long 3rd HJ, Bundy BN, Grendys jr. EC, Benda JA, McMeekin DS, Sorosky J, et al. Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study. J Clin Oncol 2005; 23: 4626-33.
-
(2005)
J Clin Oncol
, vol.23
, pp. 4626-4633
-
-
Long III, H.J.1
Bundy, B.N.2
Grendys Jr., E.C.3
Benda, J.A.4
McMeekin, D.S.5
Sorosky, J.6
-
18
-
-
0022610203
-
Treatment of metastatic and recurrent cervix cancer with chemotherapy: A randomised trial comparing hydroxyurea with cisdiamminedichloro-platinum plus methotrexate
-
Bezwoda W, Nissenbaum M, Derman D. Treatment of metastatic and recurrent cervix cancer with chemotherapy: a randomised trial comparing hydroxyurea with cisdiamminedichloro-platinum plus methotrexate. Med Pediatr Oncol 1986; 14: 17-9.
-
(1986)
Med Pediatr Oncol
, vol.14
, pp. 17-19
-
-
Bezwoda, W.1
Nissenbaum, M.2
Derman, D.3
-
19
-
-
0028242566
-
Chemotherapy of recurrent/advanced cervical cancer: Results of the Yale University PBM-PFU protocol
-
Chambers SK, Lamb L, Kohorn EI, Schwartz PE, Chambers JT. Chemotherapy of recurrent/advanced cervical cancer: results of the Yale University PBM-PFU protocol. Gynecol Oncol 1994; 53: 161-9.
-
(1994)
Gynecol Oncol
, vol.53
, pp. 161-169
-
-
Chambers, S.K.1
Lamb, L.2
Kohorn, E.I.3
Schwartz, P.E.4
Chambers, J.T.5
-
20
-
-
0022482045
-
A phase II study of carboplacin in advanced squamous cell carcinoma of the cervix (a Gynecologic Oncology Group Study)
-
Arsentau J, Blessing JA, Stehman FB, McGehee R. A phase II study of carboplacin in advanced squamous cell carcinoma of the cervix (a Gynecologic Oncology Group Study). Invest New Drugs 1986; 4: 187-91.
-
(1986)
Invest New Drugs
, vol.4
, pp. 187-191
-
-
Arsentau, J.1
Blessing, J.A.2
Stehman, F.B.3
McGehee, R.4
-
21
-
-
0024350119
-
A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: A Gynecologic Oncology Group study
-
McGuire 3rd WP, Arseneau J, Blessing JA, DiSaia PJ, Hatch KD, Given FT, et al. A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study. J Clin Oncol 1989; 7: 1462-8.
-
(1989)
J Clin Oncol
, vol.7
, pp. 1462-1468
-
-
McGuire III, W.P.1
Arseneau, J.2
Blessing, J.A.3
Disaia, P.J.4
Hatch, K.D.5
Given, F.T.6
-
22
-
-
0347623112
-
New drugs in the treatment of recurrent or metastatic cervical cancer
-
Savarese A, Cognetti F. New drugs in the treatment of recurrent or metastatic cervical cancer. Crit Rev Oncol Hematol 2003; 48: 323-7.
-
(2003)
Crit Rev Oncol Hematol
, vol.48
, pp. 323-327
-
-
Savarese, A.1
Cognetti, F.2
-
23
-
-
0029865737
-
Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study
-
McGuire WP, Blessing JA, Moore D, Lentz SS, Photopulos G. Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study. J Clin Oncol 1996; 14: 792-5.
-
(1996)
J Clin Oncol
, vol.14
, pp. 792-795
-
-
McGuire, W.P.1
Blessing, J.A.2
Moore, D.3
Lentz, S.S.4
Photopulos, G.5
-
24
-
-
9544250363
-
Activity of paclitaxel in advanced or recurrent squamous cell cancer of the cervix
-
Kudelka AP, Winn R, Edwards CL, Downey G, Greenberg H, Dakhil SR, et al. Activity of paclitaxel in advanced or recurrent squamous cell cancer of the cervix. Clin Cancer Res 1996; 2: 1285-8.
-
(1996)
Clin Cancer Res
, vol.2
, pp. 1285-1288
-
-
Kudelka, A.P.1
Winn, R.2
Edwards, C.L.3
Downey, G.4
Greenberg, H.5
Dakhil, S.R.6
-
25
-
-
8944249284
-
Preliminary report of the activity of docetaxel in advanced or recurrent squamous cell cancer of the cervix
-
Kudelka AP, Verschraegen CF, Levy T, Edwards CL, Fishman A, Freedman RS, et al. Preliminary report of the activity of docetaxel in advanced or recurrent squamous cell cancer of the cervix. Anticancer Drugs 1996; 7: 398-401.
-
(1996)
Anticancer Drugs
, vol.7
, pp. 398-401
-
-
Kudelka, A.P.1
Verschraegen, C.F.2
Levy, T.3
Edwards, C.L.4
Fishman, A.5
Freedman, R.S.6
-
26
-
-
0031037244
-
Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervix
-
Verschraegen CF, Levy T, Kudelka AP, Llerena E, Ende K, Freedman RS, et al. Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervix. J Clin Oncol 1997; 15: 625-31.
-
(1997)
J Clin Oncol
, vol.15
, pp. 625-631
-
-
Verschraegen, C.F.1
Levy, T.2
Kudelka, A.P.3
Llerena, E.4
Ende, K.5
Freedman, R.S.6
-
27
-
-
0032887487
-
Results of a European Organization for Research and Treatment of Cancer/Early Clinical Studies Group phase II trial of first-line irinotecan in patients with advanced or recurrent squamous cell carcinoma of the cervix
-
Lhomme C, Fumoleau P, Fargeot P, Krakowski Y, Dieras V, Chauvergne J, et al. Results of a European Organization for Research and Treatment of Cancer/Early Clinical Studies Group phase II trial of first-line irinotecan in patients with advanced or recurrent squamous cell carcinoma of the cervix. J Clin Oncol 1999; 17: 3136-42.
-
(1999)
J Clin Oncol
, vol.17
, pp. 3136-3142
-
-
Lhomme, C.1
Fumoleau, P.2
Fargeot, P.3
Krakowski, Y.4
Dieras, V.5
Chauvergne, J.6
-
28
-
-
0000050035
-
Phase II trial of topotecan for cervical cancer of the uterus
-
Noda K, Sasaki H, Yamamoto K, Yamamoto T, Nishimura R, Sugiyama T, et al. Phase II trial of topotecan for cervical cancer of the uterus (Meeting abstract). Proc Am Soc Clin Oncol 1996: 296A.
-
(1996)
Proc Am Soc Clin Oncol
-
-
Noda, K.1
Sasaki, H.2
Yamamoto, K.3
Yamamoto, T.4
Nishimura, R.5
Sugiyama, T.6
-
29
-
-
0000315609
-
A phase II study of gemcitabine in advanced cervix carcinoma: Final data
-
Goedhals L, Bezwoda W. A phase II study of gemcitabine in advanced cervix carcinoma: final data. Proc Am Soc Clin Oncol 1996: 754A.
-
(1996)
Proc Am Soc Clin Oncol
-
-
Goedhals, L.1
Bezwoda, W.2
-
30
-
-
0033959650
-
Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: A phase II study of the gynecologic oncology group
-
Schilder RJ, Blessing JA, Morgan M, Mangan CE, Rader JS. Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a phase II study of the gynecologic oncology group. Gynecol Oncol 2000; 76: 204-7.
-
(2000)
Gynecol Oncol
, vol.76
, pp. 204-207
-
-
Schilder, R.J.1
Blessing, J.A.2
Morgan, M.3
Mangan, C.E.4
Rader, J.S.5
-
31
-
-
0031909627
-
Phase II study of vinorelbine in advanced and recurrent squamous cell carcinoma of the cervix
-
Morris M, Brader KR, Levenback C, Burke TW, Atkinson EN, Scott WR, et al. Phase II study of vinorelbine in advanced and recurrent squamous cell carcinoma of the cervix. J Clin Oncol 1998; 16: 1094-8.
-
(1998)
J Clin Oncol
, vol.16
, pp. 1094-1098
-
-
Morris, M.1
Brader, K.R.2
Levenback, C.3
Burke, T.W.4
Atkinson, E.N.5
Scott, W.R.6
-
32
-
-
0033970201
-
Phase II trial of vinorelbine in patients with advanced and/or recurrent cervical carcinoma: An EORTC Gynaecological Cancer Cooperative Group Study
-
Lhomme C, Vermorken JB, Mickiewicz E, Chevalier B, Alvarez A, Mendiola C, et al. Phase II trial of vinorelbine in patients with advanced and/or recurrent cervical carcinoma: an EORTC Gynaecological Cancer Cooperative Group Study. Eur J Cancer 2000; 36: 194-9.
-
(2000)
Eur J Cancer
, vol.36
, pp. 194-199
-
-
Lhomme, C.1
Vermorken, J.B.2
Mickiewicz, E.3
Chevalier, B.4
Alvarez, A.5
Mendiola, C.6
-
33
-
-
0027391873
-
Phase II study of pirarubicin (THP) in patients with cervical, endometrial and ovarian cancer: Study of the Clinical Screening Group of the European Organization for Research and Treatment of Cancer (EORTC)
-
Chauvergne J, Fumoleau P, Cappelaere P, Metz R, Armand JP, Chevallier B, et al. Phase II study of pirarubicin (THP) in patients with cervical, endometrial and ovarian cancer: study of the Clinical Screening Group of the European Organization for Research and Treatment of Cancer (EORTC). Eur J Cancer 1993; 29A: 350-4.
-
(1993)
Eur J Cancer
, vol.29 A
, pp. 350-354
-
-
Chauvergne, J.1
Fumoleau, P.2
Cappelaere, P.3
Metz, R.4
Armand, J.P.5
Chevallier, B.6
-
34
-
-
33646013171
-
Phase II study of capecitabine in patients with metastatic squamous cell carcinoma of the cervix
-
Moiseyenko V, Ermakova N, Orlova R, Semenova A, Protsenko S, Mikhailitchenko T. Phase II study of capecitabine in patients with metastatic squamous cell carcinoma of the cervix. Eur J Cancer 2001: 37.
-
(2001)
Eur J Cancer
, pp. 37
-
-
Moiseyenko, V.1
Ermakova, N.2
Orlova, R.3
Semenova, A.4
Protsenko, S.5
Mikhailitchenko, T.6
-
35
-
-
33645969479
-
Phase II study of capecitabine in cisplatin-pretreated metastatic or recurrent squamous cell carcinoma of the cervix
-
abstract 507 P
-
Stamatovic L, Vasovic S, Karaferic A, Tomasevic Z, Jelic S. Phase II study of capecitabine in cisplatin-pretreated metastatic or recurrent squamous cell carcinoma of the cervix. Ann Oncol 2004; (15: abstract 507 P).
-
(2004)
Ann Oncol
, Issue.15
-
-
Stamatovic, L.1
Vasovic, S.2
Karaferic, A.3
Tomasevic, Z.4
Jelic, S.5
-
36
-
-
0032744560
-
Paclitaxel, ifosfamide and cisplatin (TIP) chemotherapy for recurrent or persistent squamous-cell cervical cancer
-
Zanetta G, Fei F, Parma G, Balestrino M, Lissoni A, Gabriele A, et al. Paclitaxel, ifosfamide and cisplatin (TIP) chemotherapy for recurrent or persistent squamous-cell cervical cancer. Ann Oncol 1999; 10: 1171-4.
-
(1999)
Ann Oncol
, vol.10
, pp. 1171-1174
-
-
Zanetta, G.1
Fei, F.2
Parma, G.3
Balestrino, M.4
Lissoni, A.5
Gabriele, A.6
-
37
-
-
0036080739
-
Combination of ifosfamide, paclitaxel, and cisplatin for the treatment of metastatic and recurrent carcinoma of the uterine cervix: A phase II study of the Hellenic Cooperative Oncology Group
-
Dimopoulos MA, Papadimitriou CA, Sarris K, Aravantinos G, Kalofonos C, Gika D, et al. Combination of ifosfamide, paclitaxel, and cisplatin for the treatment of metastatic and recurrent carcinoma of the uterine cervix: a phase II study of the Hellenic Cooperative Oncology Group. Gynecol Oncol 2002; 85: 476-82.
-
(2002)
Gynecol Oncol
, vol.85
, pp. 476-482
-
-
Dimopoulos, M.A.1
Papadimitriou, C.A.2
Sarris, K.3
Aravantinos, G.4
Kalofonos, C.5
Gika, D.6
-
38
-
-
4444331623
-
The role of chemotherapy in locally advanced, metastatic and recurrent cervical cancer
-
Tambaro R, Scambia G, Di Maio M, Pisano C, Barletta E, Iaffaioli VR, et al. The role of chemotherapy in locally advanced, metastatic and recurrent cervical cancer. Crit Rev Oncol Hematol 2004; 52: 33-44.
-
(2004)
Crit Rev Oncol Hematol
, vol.52
, pp. 33-44
-
-
Tambaro, R.1
Scambia, G.2
Di Maio, M.3
Pisano, C.4
Barletta, E.5
Iaffaioli, V.R.6
-
39
-
-
0007094156
-
Paclitaxel and Carboplatin as First Line Treatment for Advanced Carcinoma of the Cervix
-
abstract 825
-
Mickiewicz E. Paclitaxel and Carboplatin as First Line Treatment for Advanced Carcinoma of the Cervix. Proc Am Soc Clin Oncol 2001; (abstract 825).
-
(2001)
Proc Am Soc Clin Oncol
-
-
Mickiewicz, E.1
-
40
-
-
4744362969
-
Paclitaxel and carboplatin for recurrent or persistent cancer of the cervix
-
Sit AS, Kelley JL, Gallion HH, Kunschner AJ, Edwards RP. Paclitaxel and carboplatin for recurrent or persistent cancer of the cervix. Cancer Invest 2004; 22: 368-73.
-
(2004)
Cancer Invest
, vol.22
, pp. 368-373
-
-
Sit, A.S.1
Kelley, J.L.2
Gallion, H.H.3
Kunschner, A.J.4
Edwards, R.P.5
-
41
-
-
0037498599
-
Phase II clinical study of irinotecan and cisplatin as first-line chemotherapy in metastatic or recurrent cervical cancer
-
Chitapanarux I, Tonusin A, Sukthomya V, Charuchinda C, Pukanhapan N, Lorvidhaya V. Phase II clinical study of irinotecan and cisplatin as first-line chemotherapy in metastatic or recurrent cervical cancer. Gynecol Oncol 2003; 89: 402-7.
-
(2003)
Gynecol Oncol
, vol.89
, pp. 402-407
-
-
Chitapanarux, I.1
Tonusin, A.2
Sukthomya, V.3
Charuchinda, C.4
Pukanhapan, N.5
Lorvidhaya, V.6
-
43
-
-
33645961479
-
A pilot phase II study of cisplatin and capecitabine in patients with recurrent cervical carcinoma
-
Benjapibal M, Tresukosol D, Vasuratana A, Kasemsarn P, Mekariya P. A pilot phase II study of cisplatin and capecitabine in patients with recurrent cervical carcinoma. Eur J Cancer Supplements 2003; 1: S58.
-
(2003)
Eur J Cancer Supplements
, vol.1
-
-
Benjapibal, M.1
Tresukosol, D.2
Vasuratana, A.3
Kasemsarn, P.4
Mekariya, P.5
-
44
-
-
1142269367
-
A phase II trial to evaluate efficacy and safety of gefitinib (ZD1839) in patients with loco-regionally advanced or metastatic squamous-cell carcinoma of the cervix
-
abstr 1833
-
Viens P, Lhommé C, Extra J, Gladieff L, Kalla, SFabbro M. A phase II trial to evaluate efficacy and safety of gefitinib (ZD1839) in patients with loco-regionally advanced or metastatic squamous-cell carcinoma of the cervix. Proc Am Soc Clin Oncol 2003; 22: 456; (abstr 1833).
-
(2003)
Proc Am Soc Clin Oncol
, vol.22
, pp. 456
-
-
Viens, P.1
Lhommé, C.2
Extra, J.3
Gladieff, L.4
Kalla, S.5
Fabbro, M.6
-
45
-
-
9944238925
-
Phase II study of carboplatin and whole body hyperthetmia (WBH) in recurrent and metastatic cervical cancer
-
Richel O, Zum Vorde Sive Vording PJ, Rietbroek R, Van der Velden J, Van Dijk JD, Schilthuis MS, et al. Phase II study of carboplatin and whole body hyperthetmia (WBH) in recurrent and metastatic cervical cancer. Gynecol Oncol 2004; 95: 680-5.
-
(2004)
Gynecol Oncol
, vol.95
, pp. 680-685
-
-
Richel, O.1
Zum Vorde Sive Vording, P.J.2
Rietbroek, R.3
Van Der Velden, J.4
Van Dijk, J.D.5
Schilthuis, M.S.6
-
46
-
-
0037198442
-
Vaccination with HPV-18 E7-pulsed dendritic cells in a patient with metastatic cervical cancer
-
Santin AD, Bellone S, Gokden M, Cannon MJ, Parham GP. Vaccination with HPV-18 E7-pulsed dendritic cells in a patient with metastatic cervical cancer. N Engl J Med 2002; 346: 1752-3.
-
(2002)
N Engl J Med
, vol.346
, pp. 1752-1753
-
-
Santin, A.D.1
Bellone, S.2
Gokden, M.3
Cannon, M.J.4
Parham, G.P.5
-
47
-
-
0032831008
-
Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: A gynecologic oncology group study
-
Rose PG, Blessing JA, Gershenson DM, McGehee R. Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol 1999; 17: 2676-80.
-
(1999)
J Clin Oncol
, vol.17
, pp. 2676-2680
-
-
Rose, P.G.1
Blessing, J.A.2
Gershenson, D.M.3
McGehee, R.4
-
48
-
-
0025340840
-
A phase II trial of cisplatin and 5-fluorouracil with allopurinol for recurrent or metastatic carcinoma of the uterine cervix: A Southwest Oncology Group trial
-
Weiss GR, Green S, Hannigan EV, Boutselis JG, Surwit EA, Wallace DL, et al. A phase II trial of cisplatin and 5-fluorouracil with allopurinol for recurrent or metastatic carcinoma of the uterine cervix: a Southwest Oncology Group trial. Gynecol Oncol 1990; 37: 354-8.
-
(1990)
Gynecol Oncol
, vol.37
, pp. 354-358
-
-
Weiss, G.R.1
Green, S.2
Hannigan, E.V.3
Boutselis, J.G.4
Surwit, E.A.5
Wallace, D.L.6
-
49
-
-
0026799423
-
Bleomycin-ifosfamide-cis-platinum (BIP) in pelvic recurrence of previously irradiated cervical carcinoma: A second look
-
Ramm K, Vergote IB, Kaern J, Trope CG. Bleomycin-ifosfamide-cis-platinum (BIP) in pelvic recurrence of previously irradiated cervical carcinoma: a second look. Gynecol Oncol 1992; 46: 203-7.
-
(1992)
Gynecol Oncol
, vol.46
, pp. 203-207
-
-
Ramm, K.1
Vergote, I.B.2
Kaern, J.3
Trope, C.G.4
-
50
-
-
0036356151
-
Vinorelbine and cisplatin for the treatment of recurrent and/or metastatic carcinoma of the uterine cervix
-
Gebbia V, Caruso M, Testa A, Mauceri G, Borsellino N, Chiarenza M, et al. Vinorelbine and cisplatin for the treatment of recurrent and/or metastatic carcinoma of the uterine cervix. Oncology 2002; 63: 31-7.
-
(2002)
Oncology
, vol.63
, pp. 31-37
-
-
Gebbia, V.1
Caruso, M.2
Testa, A.3
Mauceri, G.4
Borsellino, N.5
Chiarenza, M.6
-
51
-
-
0033957908
-
A phase II study of gemcitabine and cisplatin in patients with advanced, persistent, or recurrent squamous cell carcinoma of the cervix
-
Burnett AF, Roman LD, Garcia AA, Muderspach LI, Brader KR, Morrow CP. A phase II study of gemcitabine and cisplatin in patients with advanced, persistent, or recurrent squamous cell carcinoma of the cervix. Gynecol Oncol 2000; 76: 63-6.
-
(2000)
Gynecol Oncol
, vol.76
, pp. 63-66
-
-
Burnett, A.F.1
Roman, L.D.2
Garcia, A.A.3
Muderspach, L.I.4
Brader, K.R.5
Morrow, C.P.6
-
52
-
-
0027341641
-
Chemotherapy of cancers of the uterine cervix with a combination of bleomycin, mitomycin, cisplatin and etoposide
-
Chauvergne J, Heron JF, Mayer F, Charrot-Chinet P, Toulouse C. Chemotherapy of cancers of the uterine cervix with a combination of bleomycin, mitomycin, cisplatin and etoposide. Bull Cancer 1993; 80: 70-9.
-
(1993)
Bull Cancer
, vol.80
, pp. 70-79
-
-
Chauvergne, J.1
Heron, J.F.2
Mayer, F.3
Charrot-Chinet, P.4
Toulouse, C.5
-
53
-
-
0035498749
-
Phase II srudy of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix
-
Verschraegen CF, Kavanagh JJ, Loyer E, Bodurka-Bevers D, Kudelka AP, Hu W, et al. Phase II srudy of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix. Cancer 2001; 92: 2327-33.
-
(2001)
Cancer
, vol.92
, pp. 2327-2333
-
-
Verschraegen, C.F.1
Kavanagh, J.J.2
Loyer, E.3
Bodurka-Bevers, D.4
Kudelka, A.P.5
Hu, W.6
-
54
-
-
0036227178
-
Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix
-
Fiorica J, Holloway R, Ndubisi B, Orr J, Grendys E, Boothby R, et al. Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix. Gynecol Oncol 2002; 85: 89-94.
-
(2002)
Gynecol Oncol
, vol.85
, pp. 89-94
-
-
Fiorica, J.1
Holloway, R.2
Ndubisi, B.3
Orr, J.4
Grendys, E.5
Boothby, R.6
-
55
-
-
0842288949
-
Phase II study of topotecan and paclitaxel for recurrent, persistent, or metastatic cervical carcinoma
-
Tiersten AD, Selleck MJ, Hershman DL, Smith D, Resnik EE, Troxel AB, et al. Phase II study of topotecan and paclitaxel for recurrent, persistent, or metastatic cervical carcinoma. Gynecol Oncol 2004; 92: 635-8.
-
(2004)
Gynecol Oncol
, vol.92
, pp. 635-638
-
-
Tiersten, A.D.1
Selleck, M.J.2
Hershman, D.L.3
Smith, D.4
Resnik, E.E.5
Troxel, A.B.6
|